Navigation Links
Bayer Introduces Fitness Program for Children and Young Adults with Hemophilia A
Date:10/26/2010

WAYNE, N.J., Oct. 26 /PRNewswire/ -- Bayer HealthCare is introducing a fitness program to help children ages 7-12 and young adults ages 13-16 with hemophilia A live active lives.  "Living Fit! A Joint Effort" is a unique strength training, fitness and wellness program created to increase awareness of the importance of exercise and nutrition among this population and their caregivers.

Fitness and healthy eating are especially important because strong muscles and a lower body weight may help maintain joint health, an important consideration for people with hemophilia A.  According to the Centers for Disease Control and Prevention, the rates of overweight and obesity among children and adolescents with hemophilia are similar to those among the general population, which are currently at epidemic proportions(1).

Living Fit! is designed to help protect and maintain joints before they become damaged from repeated bleeds.  The program offers videos, information and resources, available at www.livingwithhemophilia.com/webapp/livingfit, designed to promote a healthy lifestyle and engagement in appropriate types of exercise.  It focuses on four pillars of health: general wellness, nutrition, cardiovascular exercises and strengthening exercises.  

Living Fit! was inspired by Corey Pierce, a 24-year-old with hemophilia A and a former participant in the Bayer Hemophilia Leadership Development Program.

"I am thrilled to be able to introduce Living Fit! to help people like me maintain a healthy body – and healthy joints – as we continue to grow and develop into adulthood," Pierce said.  "It is my hope that the program can be a valuable, relevant resource for future generations of young people living with hemophilia."

A Living Fit! symposium is being held at November's annual meeting of the National Hemophilia Foundation to further encour
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... March 3, 2015, order from the Federal Drug Administration (FDA) ... to clarify the drugs, intended use and warn about a ... protect the public from injury from these products, according to ... Conroy . The order says that the drug ... taken by millions of U.S. men – are approved only ...
(Date:3/4/2015)... , March 4, 2015 XBiotech ... pilot study in patients with moderate to severe ... The open-label Phase II trial evaluated the potential ... antibody that targets interleukin-1 alpha (IL-1a). IL-1a is ... cells present in skin lesions. The Company claims ...
(Date:3/4/2015)... Minn. , March 4, 2015   Mayo ... an agreement to develop the next generation of wearable ... "We are hoping that this technology will be game-changer. ... and diabetes," says James Levine, M.D., Ph.D. , ... "They are accurate, inexpensive, and can be integrated into ...
Breaking Medicine Technology:Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3
... Anti-Viral Applications of Novel Targeted Agents Under ... Technology Platform -, - Anti-Viral Potential of ... at American Association of Immunologists Annual Meeting -, ... PPHM ), a clinical stage biopharmaceutical,company developing monoclonal antibodies ...
... Cardinal Health, a,global provider of products and ... care, today announced that it will now manufacture,compound ... trials., The company,s new services for the ... of Nuclear Medicine,s (SNM) 55th Annual Meeting,taking place ...
Cached Medicine Technology:Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 2Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 3Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 4Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials 2
(Date:3/4/2015)... (PRWEB) March 04, 2015 RapidScale, a ... in Las Vegas, Nevada, on March 16th-18th. They are ... will have some of its top engineering executives in ... in the RapidScale solution set. Attendees include William Hiatt, ... Cloud Engineer; and Ryan Turpin, Cloud Support Manager. ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 SIGVARIS ... microfiber technology and their first compression therapy collection designed ... of this collection, SIGVARIS USA is proud to announce ... MICROFIBER product line. , Constructed from a unique, extremely ... comfort in mind. These socks and thigh-highs offer a ...
(Date:3/4/2015)... March 04, 2015 The Alliance ... leaders for its upcoming fifth annual Advanced Therapies ... France. The event this year will feature five ... 20 of the field’s leading companies and organizations. ... top executives and clinical researchers from the advanced ...
(Date:3/4/2015)... Jeannie Mai, TV personality, fashion maven, and ... cover of the print publication. Mai embraces the overall theme ... shopping for clothes and personal care products. In an exclusive ... commitment to an organic diet. She mentions, “Having an organic ... gymnastics, but also now as I’m a full time student ...
(Date:3/4/2015)... March 04, 2015 i2i Systems ... selected by Chase Brexton Health Care, a 35-year-old ... , Chase Brexton provides comprehensive primary care, behavioral ... patients across seven clinics in the greater Baltimore ... electronic medical records, the organization has always focused ...
Breaking Medicine News(10 mins):Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 2Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 3Health News:Building on the Success of MIDTOWN MICROFIBER, SIGVARIS Expands Popular Compression Collection with Longer Foot Length Offerings 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 2Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 3
... survey to indicate a racial disparity in the psychological ... that African American seniors could be twice as likely ... survey also revealed that African American elders could be ... Reporting the survey results in The Gerontologist, ...
... recent years, several guidelines in the treatment of posttraumatic ... guidelines across the health sphere are very important in ... high level of consensus on these guidelines among practitioners, ... among providers, patients, and purchasers of mental health services ...
... Circulating tumor cells (CTCs) may be a promising alternative, ... to data presented at the Fourth AACR International Conference ... "The basic idea is that CTCs can provide real-time ... a ,liquid biopsy," said Siminder Kaur Atwal, Ph.D., senior ...
... Individual cancer-causing mutations have a minute effect on tumor ... 0.4 percent on average, according to new mathematical modeling ... other institutions. Their research, appearing this week in ... , reinforces that cancer is the culmination of many ...
... Warsaw, Poland: The Interdisciplinary Centre for Mathematical and Computational ... American Association for the Advancement of Science (AAAS) in ... and scientific institutions throughout Poland with site-wide access to ... , The ICM is coordinating a program entitled "Virtual ...
... Health has received a US patent for a new ... to deliver an antigen and DNA adjuvant. Chairman of ... Professor of Medicine Steve Dow, PhD, developed the new ... an infectious organism, generally work fine by themselves. But ...
Cached Medicine News:Health News:African-American seniors at twice the risk for mental abuse, 5 times for financial exploitation 2Health News:African-American seniors at twice the risk for mental abuse, 5 times for financial exploitation 3Health News:Leading practitioners recommend global PTSD treatment guidelines 2Health News:Circulating tumor cells can provide 'real-time' information on patient's current disease state 2Health News:Individual mutations are very slow to promote tumor growth 2Health News:The University of Warsaw obtains 3-year site license to Science to provide site-wide access to research institutions in Poland 2
Designed to remove cell debris or tissue remnants from the retina....
... The Medtronic Model 6495 Bipolar Coaxial Temporary ... advantages of bipolar technology based on the ... Model 6500 Unipolar Temporary Pacing Lead., ,The ... provide consistent temporary sensing and pacing during ...
... of temporary sensing and pacing leads. Our ... temporary pacing leads and improved upon the ... and less traumatic to heart tissue. , ... to provide consistent temporary sensing and pacing ...
... The eNcloseII proximal anastomosis assist device ... for partial clamping of the aorta. The ... a stable, bloodless field and dramatically better ... An increasing number of studies have suggested ...
Medicine Products: